AC
HOOK

Armistice Capital’s HOOKIPA Pharma HOOK Stock Holding History

Armistice Capital’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-371,200
Closed -$2.29M – 328
2023
Q3 		$2.29M Sell
371,200
-14,400
-4% -$106K 0.04% 132
2023
Q2 		$3.39M Buy
+385,600
New +$4.28M 0.05% 129

Other funds holding HOOK

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Armistice Capital's HOOK Position: Q4 2023 in Review

Armistice Capital sold out of HOOKIPA Pharma (HOOK) in Q4 2023, closing a stake of 371,200 shares — an estimated $2.29M sold.

Armistice Capital first reported a position in HOOK in Q2 2023 and held it in 2 quarters. The position peaked at $3.39M in Q2 2023. 41 funds tracked by Wall St. Rank hold HOOK as of Q4 2023.

  • Armistice Capital reported no remaining HOOKIPA Pharma position as of Q4 2023 after selling out during the quarter.
  • Armistice Capital sold 371,200 HOOKIPA Pharma shares in Q4 2023, an estimated $2.29M.
  • Armistice Capital first reported a position in HOOKIPA Pharma in Q2 2023 and held it in 2 quarters.
  • Armistice Capital's HOOKIPA Pharma position peaked at $3.39M in Q2 2023.
  • 41 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2023.

Based on Armistice Capital's 13F filing for Q4 2023, filed 13 Feb 2024.